The markets are treacherous waters for individual investors, but we've devised a trading system that can outwit Wall Street’s predators. Read More
Analyst Articles
Marijuana legalization is generally popular, but there’s a wide partisan gap on the issue. The political conflict over cannabis rages on. Read More
Consumers and investors in the U.S. are shrugging off threats such as the coronavirus to focus on the good economic news at home. Read More
The deadly illness is increasingly mentioned as a headwind during this season’s earnings calls. We assess the damage so far. Read More
Slowing growth overseas threatens the U.S. expansion and bull market, a prognosis worsened by the coronavirus epidemic. Read More
Efforts to end the federal ban on marijuana have stalled. We review the current relationship between the feds and Mary Jane. Read More
In a watershed for canna-business, the former seat of the Confederacy is about to legalize pot. Will the rest of Dixie follow? Read More
A spike in the number of deaths from the virus is unnerving investors all over again. Here’s an investment theme that’s immune. Read More
Fourth-quarter 2019 earnings are coming in better than expected, but the epidemic already is casting a pall over the first quarter. Read More
Media and telecom giants are engaged in brutal competition for market share in providing digitized, on-demand content. Huge profits are at stake. Read More